Chemours Market Sentiment

The Chemours Co

CCNYSE

$13.53

0.342.58%

Últ. Act.: Oct 30, 4:59 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Ganancias: Los beneficios de Q3 2026 mañana en lun nov 2nd después del cierre del mercado

Conferencia telefónica: Conferencia telefónica programada para mañana a las 8:00 a. m.

Haz clic para ver el webcast

Chemours Market Sentiment - Benzinga

Chemours Market Sentiment

Market sentiment signals for Chemours (CC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 13.8% short float

Options Flow▼ 1.08 P/C ratio

Insider Activity— N/A

Analyst Consensus

Neutral

10 analysts

Options Flow (P/C)

1.08

More puts — Bearish

1,060 calls · 1,148 puts

Avg Consensus PT

$17

+29.6%

Highest Price Target

$22

+63.8%

RBC Capital

Lowest Price Target

$13

-3.2%

Barclays

Short Interest

13.8%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 20, 2026	Truist Securities	Peter Osterland—	+48.9%	$24 → $20	Maintained	Buy
Oct 14, 2026	Mizuho	John Roberts—	+11.7%	$18 → $15	Downgrade	Outperform→Neutral
Oct 13, 2026	Barclays	Aleksey Yefremov—	+19.1%	$16	Initiate	Equal-Weight
Oct 5, 2026	UBS	Joshua Spector—	+19.1%	$18 → $16	Maintained	Neutral
Sep 30, 2026	Mizuho	John Roberts—	+34.0%	$20 → $18	Maintained	Outperform
Aug 13, 2026	JP Morgan	Jeffrey Zekauskas—	+11.7%	$22 → $15	Maintained	Neutral
Aug 13, 2026	BMO Capital	John McNulty—	+34.0%	$26 → $18	Maintained	Outperform
Aug 10, 2026	UBS	Joshua Spector—	+34.0%	$29 → $18	Downgrade	Buy→Neutral
Aug 6, 2026	RBC Capital	Arun Viswanathan—	+63.8%	$26 → $22	Maintained	Outperform
Aug 6, 2026	Truist Securities	Peter Osterland—	+78.7%	$30 → $24	Maintained	Buy
Jul 1, 2026	Mizuho	John Roberts—	+86.2%	$30 → $25	Maintained	Outperform
May 21, 2026	JP Morgan	Jeffrey Zekauskas—	+63.8%	$17 → $22	Maintained	Neutral
May 11, 2026	Morgan Stanley	Vincent Andrews—	+56.4%	$17 → $21	Maintained	Equal-Weight
May 11, 2026	RBC Capital	Arun Viswanathan—	+115.9%	$26 → $29	Maintained	Outperform
May 8, 2026	UBS	Joshua Spector—	+123.4%	$29 → $30	Maintained	Buy
Apr 28, 2026	Truist Securities	Peter Osterland—	+123.4%	$27 → $30	Maintained	Buy
Apr 9, 2026	UBS	Joshua Spector—	+115.9%	$23 → $29	Maintained	Buy
Apr 9, 2026	Truist Securities	Peter Osterland—	+101.0%	$21 → $27	Maintained	Buy
Mar 5, 2026	Mizuho	John Roberts—	+56.4%	$17 → $21	Maintained	Outperform
Feb 25, 2026	Goldman Sachs	Duffy Fischer—	+34.0%	$14 → $18	Maintained	Neutral
Feb 23, 2026	UBS	Joshua Spector—	+71.3%	$18 → $23	Maintained	Buy
Feb 23, 2026	BMO Capital	John McNulty—	+41.5%	$20 → $19	Maintained	Outperform
Feb 23, 2026	JP Morgan	Jeffrey Zekauskas—	+26.6%	$13 → $17	Maintained	Neutral
Feb 23, 2026	Morgan Stanley	Vincent Andrews—	+26.6%	$15 → $17	Maintained	Equal-Weight
Jan 21, 2026	Truist Securities	Peter Osterland—	+56.4%	$18 → $21	Maintained	Buy

Insider & Market Activity News

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

- SEC Filing

Benzinga Newsdesk

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 729 companies set new 52-week lows.

Benzinga Insights

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Charles Gross

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Charles Gross

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Charles Gross

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

Charles Gross

The Chemours Co

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Chemours Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

Stocks That Hit 52-Week Lows On Tuesday

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

People Also Watch

Bulls vs Bears

People Also Watch

The Chemours Co

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Chemours Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PROChemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

Stocks That Hit 52-Week Lows On Tuesday

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

People Also Watch

Bulls vs Bears

People Also Watch

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share